DEGIACOMI, GIULIA
 Distribuzione geografica
Continente #
NA - Nord America 708
EU - Europa 490
AS - Asia 194
OC - Oceania 2
SA - Sud America 2
AF - Africa 1
Totale 1.397
Nazione #
US - Stati Uniti d'America 699
IE - Irlanda 241
CN - Cina 146
IT - Italia 83
FI - Finlandia 57
DE - Germania 33
SG - Singapore 32
UA - Ucraina 25
SE - Svezia 11
BE - Belgio 10
AT - Austria 9
CA - Canada 9
GB - Regno Unito 8
IN - India 7
FR - Francia 3
RO - Romania 3
RU - Federazione Russa 3
AU - Australia 2
CZ - Repubblica Ceca 2
TH - Thailandia 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
BR - Brasile 1
CL - Cile 1
EG - Egitto 1
GR - Grecia 1
HK - Hong Kong 1
MY - Malesia 1
NL - Olanda 1
PK - Pakistan 1
TW - Taiwan 1
Totale 1.397
Città #
Dublin 241
Chandler 185
Ashburn 63
Boardman 54
Helsinki 44
Pavia 43
Jacksonville 36
Lawrence 30
Medford 30
Princeton 30
Shanghai 30
Beijing 25
Nanjing 25
Singapore 23
Wilmington 17
New York 16
Nanchang 12
Los Angeles 9
Ann Arbor 8
Changsha 8
Hangzhou 8
Piscataway 8
Shenyang 8
Vienna 8
Brussels 7
Jiaxing 7
San Genesio ed Uniti 7
Cinisello Balsamo 6
Hebei 6
Ottawa 6
Washington 5
Milan 4
Tianjin 4
Woodbridge 4
Achel 3
Dearborn 3
Fiorano Modenese 3
Pune 3
Toronto 3
Bangkok 2
Chicago 2
Cluj-Napoca 2
Fairfield 2
Falkenstein 2
Frankfurt am Main 2
Hyderabad 2
Kunming 2
London 2
Marcallo Con Casone 2
Melbourne 2
Olomouc 2
San Francisco 2
San Martino in Strada 2
Seattle 2
Shimla 2
Taizhou 2
Verona 2
West Jordan 2
Auburn Hills 1
Baoding 1
Buffalo 1
Cairo 1
Corteolona 1
Focsani 1
Fuzhou 1
Gunzenhausen 1
Handan 1
Houston 1
Islamabad 1
La Canada Flintridge 1
Legnano 1
Lodi 1
Manassas 1
Munich 1
Naples 1
Newark 1
Phoenix 1
Pioltello 1
Reading 1
Redwood City 1
Rockville 1
Taipei 1
Taiyuan 1
Tappahannock 1
Voghera 1
Totale 1.097
Nome #
Analogous mechanisms of resistance to benzothiazinones and dinitrobenzamides in Mycobacterium smegmatis 88
Biological and structural characterization of theMycobacterium smegmatis nitroreductase NfnB, and its rolein benzothiazinone resistance 86
Clinical Isolates of Mycobacterium tuberculosis in Four European Hospitals are Uniformly Susceptible to Benzothiazinones 77
Thiophenecarboxamide Derivatives Activated by EthA Kill Mycobacterium tuberculosis by Inhibiting the CTP Synthetase PyrG. 73
A phenotypic based target screening approach delivers new antitubercular CTP synthetase inhibitors 71
Decaprenylphosphoryl-beta-D-ribose 2’-epimerase from Mycobacterium tuberculosis is a magic drug target. 68
Structural Basis for Benzothiazinone-Mediated Killing of Mycobacterium tuberculosis. 65
A multitarget approach to drug discovery inhibiting Mycobacterium tuberculosis PyrG and PanK 65
In vitro Study of Bedaquiline Resistance in Mycobacterium tuberculosis Multi-Drug Resistant Clinical Isolates. 48
New insights into the mechanism of action of the thienopyrimidine antitubercular prodrug TP053 45
A Coumarin-Based Analogue of Thiacetazone as Dual Covalent Inhibitor and Potential Fluorescent Label of HadA in Mycobacterium tuberculosis 45
Rv0579 Is Involved in the Resistance to the TP053 Antitubercular Prodrug 44
Pyridine-2-thiol 1-oxide derivatives and their use for treatment of mammalian infections caused by Mycobacterium or fungi 42
Design and Synthesis of Pyrano[3,2-b]indolones Showing Antimycobacterial Activity 41
Nitric oxide-releasing compounds for the treatment of lung infections 40
Functional investigation of the antitubercular drug target Decaprenylphosphoryl-β-D-ribofuranose-2-epimerase DprE1/DprE2 complex 39
Mycobacterium abscessus, an Emerging and Worrisome Pathogen among Cystic Fibrosis Patients. 38
First triclosan-based macrocyclic inhibitors of InhA enzyme 34
The Veterinary Anti-Parasitic Selamectin Is a Novel Inhibitor of the Mycobacterium tuberculosis DprE1 Enzyme 33
A New Benzothiazolthiazolidine Derivative, 11726172, Is Active In Vitro, In Vivo, and against Nonreplicating Cells of Mycobacterium tuberculosis 31
P146 New weapons are necessary to fight Mycobacterium abscessus 31
Age-related changes in PD-1 expression coincide with increased cytotoxic potential in Vδ2 T cells during infancy 30
The antimalarial mefloquine shows activity against mycobacterium abscessus, inhibiting mycolic acid metabolism 29
Design of Anti-infectious Agents from Lawsone in a Three-Component Reaction with Aldehydes and Isocyanides 27
Promoter mutagenesis for fine-tuning expression of essential genes in Mycobacterium tuberculosis 27
GarA is an essential regulator of metabolism in mycobacterium tuberculosis 25
CanB, a Druggable Cellular Target in Mycobacterium tuberculosis 23
Micrococcin P1 – A bactericidal thiopeptide active against Mycobacterium tuberculosis 23
Mycobacterium abscessus Infections in Cystic Fibrosis Individuals: A Review on Therapeutic Options 22
The antibacterial prodrug activator Rv2466c is a mycothiol-dependent reductase in the oxidative stress response of Mycobacterium tuberculosis 22
Essentiality of mmpL3 and impact of its silencing on Mycobacterium tuberculosis gene expression 22
Expanding the knowledge around antitubercular 5-(2-aminothiazol-4-yl)isoxazole-3-carboxamides: Hit-to-lead optimization and release of a novel antitubercular chemotype via scaffold derivatization 19
The novel drug candidate VOMG kills Mycobacterium abscessus and other pathogens by inhibiting cell division. 19
Promiscuous Targets for Antitubercular Drug Discovery: The Paradigm of DprE1 and MmpL3 19
New Drugs and Novel Cellular Targets against Tuberculosis 18
Whole cell screen based identification of spiropiperidines with potent antitubercular properties 18
PknG senses amino acid availability to control metabolism and virulence of Mycobacterium tuberculosis 15
The phosphatidyl-myo-inositol mannosyltransferase PimA is essential for Mycobacterium tuberculosis growth in vitro and in vivo 15
Implementing best practices on data generation and reporting of Mycobacterium tuberculosis in vitro assays within the ERA4TB consortium 11
Concomitant assessment of PD-1 and CD56 expression identifies subsets of resting cord blood Vδ2 T cells with disparate cytotoxic potential 10
Exploring the plasticity of the InhA substrate-binding site using new diaryl ether inhibitors 5
Distinct Effects of Moxifloxacin and Bedaquiline on Growing and 'Non-Culturable' Mycobacterium abscessus 5
Imidazoquinoline Derivatives as Potential Inhibitors of InhA Enzyme and Mycobacterium tuberculosis 2
Mechanochemical Studies on Coupling of Hydrazines and Hydrazine Amides with Phenolic and Furanyl Aldehydes—Hydrazones with Antileishmanial and Antibacterial Activities 1
Totale 1.511
Categoria #
all - tutte 8.242
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 8.242


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202081 0 0 0 0 6 6 5 22 3 22 16 1
2020/202192 9 5 1 7 10 7 4 25 6 7 9 2
2021/2022141 5 1 1 0 2 2 5 14 8 5 14 84
2022/2023598 47 54 7 33 42 59 1 34 293 7 10 11
2023/2024300 50 52 8 16 18 54 12 28 5 15 26 16
2024/2025137 22 47 31 7 30 0 0 0 0 0 0 0
Totale 1.511